EDITORIAL STANDARDS
Conflicts of
Interest
Transparency and integrity throughout the publication process depend on full disclosure of relationships or activities that could influence judgment.
Transparency first Across the whole editorial process
Bayrakol Medical Publishing is committed to ensuring transparency and integrity throughout the publication process. Authors, reviewers, editors, and editorial board members are expected to disclose any relationships or activities that could influence, or reasonably be perceived to influence, their professional judgment.
AUTHORS
Disclose related interests
Financial and non-financial
Authors must disclose all financial and non-financial conflicts of interest that are directly related to the submitted work.
If no conflicts exist, the manuscript should include the statement:
“The authors declare no conflicts of interest.”
REVIEWERS
Decline where objectivity
may be affected
Reviewers should decline invitations to review manuscripts when any personal, professional, academic, financial, or other competing interest could affect their objectivity or impartiality.
EDITORS
Recusal where needed
Scientific merit only
Editors and editorial board members must recuse themselves from the editorial handling of manuscripts in which they have a conflict of interest.
Editorial decisions must be based solely on scientific merit, editorial quality, and the journal’s policies.
MANAGEMENT OF CONFLICTS
Disclosure reviewed
Process protected
All disclosed conflicts of interest are evaluated by the editorial office. When appropriate, measures such as reviewer or editor reassignment, additional editorial oversight, disclosure in the published article, or other actions may be taken to ensure a fair and transparent editorial process.
Undisclosed conflicts of interest identified before or after publication may result in appropriate editorial action, including correction, retraction, or notification of relevant institutions, when warranted.